Latest News
A Yale psychiatrist answers questions about electroconvulsive therapy (ECT), a psychiatric treatment that involves sending electrical currents through the brain.
- October 02, 2024
A small sample of patients with bipolar disorder displayed noteworthy improvement in their depressive symptoms after being treated with the rapid-acting antidepressant intravenous ketamine and the nasal spray esketamine, according to a new Yale led-study. Mia Santucci, BA, postgraduate associate, and Samuel Wilkinson, MD, associate professor of psychiatry, are lead and senior authors, respectively.
- August 20, 2024Source: The Wall Street Journal
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The Wall Street Journal about ketamine's effect on the brain and why it can work as an antidepressant.
- May 20, 2024
Announcing the winners of the 2024 Yale School of Medicine teaching awards.
- May 02, 2024Source: The New England Journal of Medicine
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry; and Sina Nikayin, MD, assistant professor of psychiatry, are featured in the first episode of a four-part Double Take video miniseries on depression from the New England Journal of Medicine.
- April 22, 2024Source: Yale Medicine
Ebony Dix, MD, assistant professor of psychiatry, spoke to Yale Medicine about treating patients who suffer from Long COVID, which physicians say is difficult to diagnose.
- April 03, 2024Source: Psychology Today
Samuel Wilkinson, MD, associate professor of psychiatry and associate director of the Yale Depression Research Program, writes in Psychology Today about the history of ketamine, its use to treat depression, and how it compares to esketamine.
- April 02, 2024Source: Molecular Psychiatry
Henrique Oliva, MD, PhD, postdoctoral associate; Gustavo A. Angarita, MD, MHS, assistant professor of psychiatry, and Yale colleagues conducted comprehensive meta-analysis on spine density as it relates to substance use. The findings were published in Molecular Psychiatry.
- March 25, 2024Source: CNN
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry and director of the Yale Depression Research Program, spoke to CNN about the use of ketamine to treat anxiety and depression.
- March 05, 2024
Samuel T. Wilkinson, MD, associate professor of psychiatry, is author of the new book "Purpose: What Evolution And Human Nature Imply About the Meaning of Our Existence?"